Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Phillip Febbo"'
Autor:
Douglas S. Tyler, William P. Peters, Ann Marie Pendergast, Phillip Febbo, M. Angelica Selim, Patricia A. Zipfel, Mukur Gupta, Yasunori Yoshimoto, Christina K. Augustine
Malignant transformation in melanoma is characterized by a phenotype “switch” from E- to N-cadherin, which is associated with increased motility and invasiveness of the tumor and altered signaling, leading to decreased apoptosis. We hypothesized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c016f13ed2d4013990b403f2255ff59
https://doi.org/10.1158/0008-5472.c.6496268
https://doi.org/10.1158/0008-5472.c.6496268
Autor:
Massimo Loda, Phillip Febbo, Johann Zimmermann, Stephen Finn, Alessandro Porrello, Antonella Farsetti, Shuji Ogino, Ewa Sicinska, Barbara Benassi, Mohan Brahamandan, Dan Tang, Carmen Priolo
Supplementary Table 1 from The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3a00b8576ed0f4c09847000df6468a
https://doi.org/10.1158/0008-5472.22364850
https://doi.org/10.1158/0008-5472.22364850
Autor:
Douglas S. Tyler, William P. Peters, Ann Marie Pendergast, Phillip Febbo, M. Angelica Selim, Patricia A. Zipfel, Mukur Gupta, Yasunori Yoshimoto, Christina K. Augustine
Supplementary Figure 1 from Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c84c46e538ea6e9376ca569b9ea600
https://doi.org/10.1158/0008-5472.22370108
https://doi.org/10.1158/0008-5472.22370108
Autor:
Massimo Loda, Phillip Febbo, Johann Zimmermann, Stephen Finn, Alessandro Porrello, Antonella Farsetti, Shuji Ogino, Ewa Sicinska, Barbara Benassi, Mohan Brahamandan, Dan Tang, Carmen Priolo
Deubiquitinating enzymes can prevent the destruction of protein substrates prior to proteasomal degradation. The ubiquitin-specific protease 2a (USP2a) deubiquitinates the antiapoptotic proteins Fatty Acid Synthase and Mdm2. Here, we show that when U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6418d63b72d4e570b3d7c3fefd38eb26
https://doi.org/10.1158/0008-5472.c.6494394.v1
https://doi.org/10.1158/0008-5472.c.6494394.v1
Autor:
Massimo Loda, Phillip Febbo, Johann Zimmermann, Stephen Finn, Alessandro Porrello, Antonella Farsetti, Shuji Ogino, Ewa Sicinska, Barbara Benassi, Mohan Brahamandan, Dan Tang, Carmen Priolo
Supplementary Table 2 from The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6af59912e440c1e0bbee2dc0702b6f
https://doi.org/10.1158/0008-5472.22364847.v1
https://doi.org/10.1158/0008-5472.22364847.v1
Autor:
Douglas S. Tyler, William P. Peters, Ann Marie Pendergast, Phillip Febbo, M. Angelica Selim, Patricia A. Zipfel, Mukur Gupta, Yasunori Yoshimoto, Christina K. Augustine
Supplementary Methods and Materials from Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55213415c42ee14c46d56c37ada2c6b9
https://doi.org/10.1158/0008-5472.22370105
https://doi.org/10.1158/0008-5472.22370105
Autor:
Phillip Febbo
In this proposal, we aim to test the hypothesis that complete AR pathway inhibition selects for subpopulations of tumor cells that are completely independent of AR signaling and further, that these resistant cells will have activated---and be depende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a548b3981b82daf665f87fc73657954
https://doi.org/10.21236/ada560738
https://doi.org/10.21236/ada560738
Autor:
Carmen Priolo, 1, 5, 7 Dan Tang, 1 Mohan Brahamandan, 1 Barbara Benassi, 5 Ewa Sicinska, 1 Shuji Ogino, 2 Antonella Farsetti, 6 Alessandro Porrello, 4, 5 Stephen Finn, 1 Johann Zimmermann, 3 Phillip Febbo, Massimo Loda1, 2
Publikováno v:
Cancer research (Chic. Ill.) 66 (2006): 8625–8632.
info:cnr-pdr/source/autori:Carmen Priolo,1,5,7 Dan Tang,1 Mohan Brahamandan,1 Barbara Benassi,1,5 Ewa Sicinska,1 Shuji Ogino,1,2 Antonella Farsetti,5,6 Alessandro Porrello,4,5 Stephen Finn,1 Johann Zimmermann,3 Phillip Febbo,4 and Massimo Loda1,2/titolo:The isopeptidase USP2a protects human prostate cancer from apoptosis/doi:/rivista:Cancer research (Chic. Ill.)/anno:2006/pagina_da:8625/pagina_a:8632/intervallo_pagine:8625–8632/volume:66
info:cnr-pdr/source/autori:Carmen Priolo,1,5,7 Dan Tang,1 Mohan Brahamandan,1 Barbara Benassi,1,5 Ewa Sicinska,1 Shuji Ogino,1,2 Antonella Farsetti,5,6 Alessandro Porrello,4,5 Stephen Finn,1 Johann Zimmermann,3 Phillip Febbo,4 and Massimo Loda1,2/titolo:The isopeptidase USP2a protects human prostate cancer from apoptosis/doi:/rivista:Cancer research (Chic. Ill.)/anno:2006/pagina_da:8625/pagina_a:8632/intervallo_pagine:8625–8632/volume:66
Deubiquitinating enzymes can prevent the destruction of protein substrates prior to proteasomal degradation. The ubiquitin-specific protease 2a (USP2a)deubiquitinat es the antiapoptotic proteins Fatty Acid Synthase and Mdm2. Here, we show that when U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::3b72e43618b1098f043868bfa830f7ea
http://www.cnr.it/prodotto/i/4842
http://www.cnr.it/prodotto/i/4842
Autor:
David S. Hsu, Emily J. Chenette, Phillip Febbo, Anil Potti, Richard F. Riedel, Emily Pontzer, Alessandro Porrello, Joseph R. Nevins, Bala S. Balakumaran
Publikováno v:
Molecular Cancer Therapeutics. 11:1214-1215
Using previously published annotations for chemotherapy sensitivity in the NCI-60 series of cancer cell lines (2), we performed gene set enrichment analysis on predefined groups of sensitive and resistantNCI-60 cell lines for a range of chemotherapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16c52e250897f71008efd922251c9c27
https://doi.org/10.1158/1535-7163.mct-12-0210
https://doi.org/10.1158/1535-7163.mct-12-0210
